Damon R Race
Chief Executive Officer at GeneVentiv Therapeutics, Inc.
Network origin in Damon R Race first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
GeneVentiv Therapeutics, Inc.
 GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race.
2
| Holding Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Damon R Race via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Nabgen, Inc. | Director/Board Member |
Statistics
International
| United States | 2 |
Sectoral
Operational
| Director/Board Member | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Chengwen Li | 2 |
| Richard Limehouse | 1 |
- Stock Market
- Insiders
- Damon R Race
- Company connections
